Skip to main content

Latest SEC Filings — Page 16

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Stockholders Approve 1.5M Share Increase for Equity Incentive Plan, Raising Potential Dilution to ~16%
ProForm 8-KANVS · Form 8-K · 1d ago
Legend Biotech Proposes $225M Public Offering of ADSs
ProForm 424B5LEGN · Form 424B5 · 1d ago
CONMED Appoints Experienced CFO John Gallagher from Certara, Strengthening Financial Leadership
ProForm 8-KCNMD · Form 8-K · 1d ago
CEO & Entity Disclose 17.6% Stake in BBB Foods Ahead of Share Class Conversions
Form SCHEDULE 13DTBBB · Form SCHEDULE 13D · 1d ago
Ascendis Pharma Completes $187.5M Sale of Rare Pediatric Disease Priority Review Voucher
ProForm 6-KASND · Form 6-K · 1d ago
Vroom Director Sells Over $112K in Stock and Warrants
Form 4VRM · Form 4 · 1d ago
Major Investor Files to Sell $113M in TNGX Stock, Following $105M in Recent Sales
ProForm 144TNGX · Form 144 · 1d ago
Odyssey Therapeutics Reports Q1 2026 Results, Confirms Strong Liquidity Post-IPO, Extending Cash Runway into H2 2028
ProForm 10-QODTX · Form 10-Q · 1d ago
Planned CEO Transition and $12.4M Share Repurchase from Outgoing CEO
ProForm 8-KSPFI · Form 8-K · 1d ago
Odyssey Therapeutics Reports Positive Clinical Proof-of-Concept for Lead Candidate OD-001 and Strong Cash Runway
ProForm 8-KODTX · Form 8-K · 1d ago
DUOS Technologies Announces $55M Offering of Stock and Warrants at Deep Discount
ProForm 8-KDUOT · Form 8-K · 1d ago
Registers 100M ADSs to Enable $225M Public Offering
Form F-6EFLEGN · Form F-6EF · 1d ago
Fiserv Finalizes €1 Billion Senior Notes Offering to Fund Debt Repurchase
Form 8-KFISV · Form 8-K · 1d ago
Plains GP Holdings Secures New $2.7 Billion Revolving Credit Facility, Extending Maturity to 2031
ProForm 8-KPAGP · Form 8-K · 1d ago
Skkynet Reports Worsening Operating Cash Flow and Persistent Internal Control Weakness
ProForm 10-QSKKY · Form 10-Q · 1d ago
QVC Group Reports $36.3M Net Loss in First Post-Bankruptcy Operating Report
ProForm 8-KQVCPQ · Form 8-K · 1d ago
Two Directors Resign, One New Director Appointed Amidst 'Going Concern' Warning
ProForm 8-KGEVI · Form 8-K · 1d ago
Plains All American Secures New $2.7B Revolving Credit Facility, Extends Maturity to 2031
ProForm 8-KPAA · Form 8-K · 1d ago
Fiserv Finalizes €1 Billion Senior Notes Offering to Refinance Existing Debt
Form 424B5FISV · Form 424B5 · 1d ago
Innodata Appoints Jayant Chauhan as CFO, Reaffirms Strong 2026 Revenue Growth Guidance
Form 8-KINOD · Form 8-K · 1d ago
Cycurion Seeks Shareholder Approval for Reverse Stock Split (Up to 250:1) and Staggered Board to Maintain Nasdaq Listing
ProForm PRE 14ACYCU · Form PRE 14A · 1d ago
Corcept Resubmits NDA for Relacorilant in Cushing's Syndrome, Expects 6-Month FDA Review
ProForm 8-KCORT · Form 8-K · 1d ago
Smith & Wesson Reports Strong FY2026 Results with Double-Digit Sales Growth and 37% EPS Increase
ProForm 10-KSWBI · Form 10-K · 1d ago
DLH Holdings Corp. Amends Credit Agreement, Easing Debt Covenants Amid Financial Strain
ProForm 8-KDLHC · Form 8-K · 1d ago
Shareholders Approve Doubling of Authorized Common Stock to 1 Billion Shares
ProForm 8-KTE · Form 8-K · 1d ago
Allurion Technologies Announces 1-for-15 Reverse Stock Split to Aid Re-listing Efforts
ProForm 8-KALURW · Form 8-K · 1d ago
Verra Mobility Appoints Chief Customer Officer Amidst Strategic Transformation
Form 8-KVRRM · Form 8-K · 1d ago
Eagle Point Credit Co Reports Increased Estimated NAV for May
Form 497ADECC · Form 497AD · 1d ago
Shareholders Approve Issuance of 3.8 Million Shares from Warrant Exercises
ProForm 8-KGOVX · Form 8-K · 1d ago
Lunai Bioworks Secures First Revenue Contract, Confirms NASDAQ Compliance, and Initiates Short Selling Litigation
ProForm 8-KLNAI · Form 8-K · 1d ago